Clinical Trials on Neurogenic Lower Urinary Tract Dysfunction in Belgium

Total 1643 results

Pfizer

Completed

BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG

Neurogenic Detrusor Overactivity

Belgium
University of Zurich

Recruiting

Bladder and TranscUtaneous Tibial Nerve Stimulation for nEurogenic Lower Urinary Tract Dysfunction (bTUNED)

Neurogenic Bladder Dysfunction

Belgium, Brazil, Italy, Switzerland
Astellas Pharma Europe B.V.

Completed

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

Pediatric | Neurogenic Detrusor Overactivity

United States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
Pfizer

Completed

Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer

Neurogenic Detrusor Overactivity

Belgium
Astellas Pharma Inc

Completed

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Overactive Bladder | Neurogenic Detrusor Overactivity

Belgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder

Overactive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor Overactivity

Belgium, Denmark, Norway, Poland, Serbia
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

Neurogenic Detrusor Overactivity

United States, Belgium, Brazil, Denmark, Hungary, Korea, Republic of, Mexico, Philippines, Poland, Turkey
Astellas Pharma Europe B.V.

Completed

Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity (Crocodile)

Neurogenic Detrusor Overactivity

Belgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
Astellas Pharma Global Development, Inc.

Recruiting

A Study of Mirabegron in Young Children With Neurogenic Detrusor Overactivity

Neurogenic Detrusor Overactivity

Philippines, Turkey, Belgium, Denmark
Pfizer

Completed

Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.

Prostatic Hyperplasia

Australia, Denmark, Spain, Colombia, Slovakia, Chile, Canada, Finland, Italy, Poland, Greece, Belgium, United Kingdom, Latvia, Lithuania
Allergan

Completed

Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)

Multiple Sclerosis | Urinary Incontinence | Neurogenic Bladder

France, Poland, Portugal, Belgium, Canada, Russian Federation, Czechia, United States
University Hospital, Ghent

Recruiting

ZEPHYR: A Study Evaluating Surgical Outcome After Implantation of the Zephyr ZSI 475 FTM Inflatable Penile Implant in the Neophallus After Female-to-male Sex Reassignment Surgery

Gender Dysphoria | Erectile Dysfunction

Belgium
Bayer

Completed

To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction.

Erectile Dysfunction

India
MedtronicNeuro

Terminated

Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (ACCEPTANCE)

Urinary Incontinence | Detrusor Overactivity | Neurogenic Overactive Bladder

Belgium, France, United Kingdom, Germany, Italy, Netherlands
Boehringer Ingelheim

Completed

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, India, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, Brazil, Mexico, Ukraine
University Hospital, Ghent

Completed

Erectile Dysfunction and Diabetes Mellitus

Diabetes Mellitus | Erectile Dysfunction

Belgium
Boehringer Ingelheim

Completed

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, India, Brazil, Canada, Mexico, Ukraine
University Hospital, Ghent

Active, not recruiting

Impaired Toilet Training, LUTS and Bowel Dysfunction in Children With DCD

Lower Urinary Tract Symptoms | Developmental Coordination Disorder | Bowel Dysfunction

Belgium
University Hospital, Ghent
Medtronic

Completed

OptiLUTS Part C: The Development of a Symptom Assessment Tool in Sacral Neuromodulation. (OptiLUTS)

Urinary Retention | Fecal Incontinence | Overactive Bladder Syndrome | Dysfunctional Voiding | Fowler Syndrome

Belgium
Astellas Pharma Europe B.V.
Veeda Clinical Research

Completed

Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms (Overactive Bladder Syndrome) (VENICE)

Lower Urinary Tract Predominant Storage Symptoms

Belgium
Bayer

Completed

A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy. (FINDER)

Erectile Dysfunction

Belgium, Finland, Germany, France, Denmark, United Kingdom, Spain
Bayer
GlaxoSmithKline; Schering-Plough

Completed

Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction

Erectile Dysfunction

Belgium, Spain, Germany, South Africa, France, Netherlands
University Hospital, Ghent

Recruiting

Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women (HARALD)

Nocturia

Belgium
University Hospital, Ghent
University Ghent

Completed

Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children

Urologic Diseases | Lower Urinary Tract Symptoms

Belgium
Bayer

Completed

Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II

Sexual Dysfunction | Male Erectile Dysfunction

Belgium, Italy, France, Germany, Spain, Netherlands, South Africa
University Ghent

Completed

Food and Salt Handling in Diuresis

Nocturia | Polyuria

Belgium
University Hospital, Ghent

Completed

Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study

Nocturia

Belgium
Eli Lilly and Company

Completed

A Study of Tadalafil After Radical Prostatectomy (REACTT)

Erectile Dysfunction

Germany, Belgium, Spain, United Kingdom, France, Italy, Netherlands, Canada, Poland, Switzerland
University Hospital, Ghent
ELATOR/EREKTOR

Recruiting

Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients. (EROS)

Sexual Dysfunction | Gender Dysphoria | Erectile Dysfunction | Prosthesis Durability | Transgenderism

Belgium, Netherlands
Universitaire Ziekenhuizen KU Leuven

Recruiting

Lymphoedema and Nocturia/ Nocturnal Polyuria After Pelvic Lymph Node Dissection for Urogenital Cancer (UroLymph)

Urogenital Cancer | Lower Limb Lymphedema

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer (UroLymph)

Nocturia | Urogenital Cancer | Lower Limb Lymphedema | Nocturnal Polyuria

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction (COUPLE)

Sexual Dysfunction | Erectile Dysfunction

France, Poland, United States, Belgium, Mexico, Malaysia, Canada, Taiwan, Korea, Republic of, Russian Federation, Argentina, Australia, United Kingdom
Universiteit Antwerpen
Leiden University Medical Center

Unknown

Standardization of Lead Placement for Sacral Neuromodulation Part 2

Overactive Bladder | Non Obstructive Urinary Retention

Belgium
Universiteit Antwerpen
Leiden University Medical Center

Unknown

Standardization of Lead Placement for Sacral Neuromodulation. Part 1

Overactive Bladder | Non Obstructive Urinary Retention

Belgium
Universiteit Antwerpen

Unknown

Sacral Neuromodulation & Urodynamics

Overactive Bladder | Non-obstructive Urinary Retention

Belgium
Micron Medical Corporation

Terminated

Protect Chronic Tibial Nerve Stimulator (CTNS) System

Urge Incontinence

Belgium
University Hospital, Ghent

Completed

Validation of Capillary Serum Sodium Levels

Nocturia

Belgium
Universiteit Antwerpen

Unknown

Sacral Neuromodulation and Pudendal Somatic Afferents

Overactive Bladder, Non Obstructive Urinary Retention

Belgium
Bayer

Completed

Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED

Erectile Dysfunction | Sexual Dysfunction, Physiological

Belgium, Italy, Spain, France, Switzerland, Canada, Sweden, Austria, United States, Germany, United Kingdom, South Africa, Netherlands, Norway, Finland
University Hospital of Mont-Godinne

Unknown

Rule of Carbone Monoxyde in the Ex Vivo Lung Perfusion Reconditionning

Neurogenic Lung Edema

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Pelvic Floor Dysfunction and Its Influence on Body Image and Sexual Function (PFD-BI)

Urinary Incontinence | Constipation | Sexual Dysfunction | Pelvic Organ Prolapse | Pregnancy Related | Body Image | Anal Incontinence | Postpartum Disorder | Anorectal Disorder

Belgium
University Hospital, Ghent

Completed

Voiding Class Study for Symptom Reduction and Quality of Life in Children With LUTS

Lower Urinary Tract Symptoms

Belgium
Amphora Medical, Inc.

Terminated

Cystoscopic Ablation Via RF Energy Clinical Trial (CARETI)

Overactive Bladder

Canada, Belgium
University Hospital, Ghent
Astellas Pharma Inc; Medtronic

Completed

Treatment of the Overactive Bladder Syndrome: A Delphi Study

Overactive Bladder Syndrome

Belgium
University Hospital, Ghent

Terminated

TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I) (TaPaS)

Overactive Bladder Syndrome

Belgium
European Association of Urology Research Foundation
Boston Scientific Corporation; Coloplast A/S

Recruiting

Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction (PHOENIX)

Erectile Dysfunction

Spain, Belgium, Sweden, France, Italy, United Kingdom, Germany, Portugal
University Hospital, Ghent

Completed

Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation (TM)

Enuresis | Polyuria

Belgium
Universitair Ziekenhuis Brussel

Completed

Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the ICU: a Retrospective Analysis

Nephrogenic Diabetes Insipidus

Belgium
Université Catholique de Louvain

Recruiting

Temocillin Pharmacokinetics in Paediatrics (TEMOPEDI)

Urinary Tract Infection | Infection | Liver Dysfunction

Belgium
University Hospital, Ghent
Ferring Pharmaceuticals

Completed

Desmopressin Melt: Impact on Sleep and Daytime Functioning (SLEEP)

Monosymptomatic Nocturnal Enuresis

Belgium

Clinical Trials on Neurogenic Lower Urinary Tract Dysfunction in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations